Pectoral Nerve Blockade in Mastectomy

NCT01943240 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Insufficient population of eligible patients; none enrolled

Conditions

Postoperative Pain
Breast Cancer

Interventions

DRUG: Paravertebral nerve block: 4 mL ropivacaine 0.5% at each of six levels
DRUG: 10 cc of 0.375% ropivacaine pectoral nerve block

Sponsor

Timothy R Petersen